Content about Brunswick

July 16, 2012

CareOne, a senior care company, last week announced that it has teamed with Walgreens to introduce a program that will provide day-of-discharge medications to patients before they leave CareOne centers.

EAST BRUNSWICK, N.J. — CareOne, a senior care company, last week announced that it has teamed with Walgreens to introduce a program that will provide day-of-discharge medications to patients before they leave CareOne centers.

“Healthcare providers are increasingly being challenged to find creative ways to improve outcomes for patients,” stated Tim Hodges, chief strategy officer for CareOne. “Relationships with forward-thinking organizations like Walgreens demonstrate our deep commitment to changing the way health care is delivered.”

March 16, 2012

Another generic drug maker has joined efforts to challenge the patent on a drug made by Forest Labs for treating hypertension.

NEW YORK — Another generic drug maker has joined efforts to challenge the patent on a drug made by Forest Labs for treating hypertension.

August 17, 2011

Patients with gout taking a drug made by Savient Pharmaceuticals experienced "significant" improvements, according to results of two late-stage clinical trials published in the Journal of the American Medical Association.

EAST BRUNSWICK, N.J. — Patients with gout taking a drug made by Savient Pharmaceuticals experienced "significant" improvements, according to results of two late-stage clinical trials published in the Journal of the American Medical Association.

May 26, 2011

Grocer A&P recently completed the previously announced auction of 25 Southern Superfresh locations as it continues to implement its financial and operational restructuring, the company announced on Wednesday.

MONTVALE, N.J. — Grocer A&P recently completed the previously announced auction of 25 Southern Superfresh locations as it continues to implement its financial and operational restructuring, the company announced on Wednesday.

The winning bids, which are subject to approval from the bankruptcy court before the sales would be completed, will be listed in motions of the company to be filed with the court on May 27. The winning bids are as follows:

February 25, 2011

Savient said its newest drug is the first and only therapy available to treat chronic gout in adult patients refractory to conventional therapy.

EAST BRUNSWICK, N.J. — Savient said its newest drug is the first and only therapy available to treat chronic gout in adult patients refractory to conventional therapy.

The drug maker announced the U.S. commercial launch of Krystexxa (pegloticase).

February 18, 2011

NEW BRUNSWICK, N.J. — McNeil Consumer’s absence from cough-cold and analgesic aisles, including several pediatric formulations, will extend into the fourth quarter, Johnson and Johnson executives told analysts in January. 


February 17, 2011

Savient Pharmaceuticals announced changes to its management team as it gears up for the commercial launch of its chronic gout treatment.

EAST BRUNSWICK, N.J. — Savient Pharmaceuticals announced changes to its management team as it gears up for the commercial launch of its chronic gout treatment.

The drug maker appointed Louis Ferrari as its SVP corporate development, Christine Mikail as SVP and Stephen Davies as chief information officer and group VP.

January 3, 2011

3Rx Skin Therapy has announced the introduction of a new skin care line to help repair and rejuvenate skin damaged by such cancer treatments as chemotherapy and radiation, and other dry skin issues caused by medical conditions.

SOUTH BRUNSWICK, N.J. — 3Rx Skin Therapy has announced the introduction of a new skin care line to help repair and rejuvenate skin damaged by such cancer treatments as chemotherapy and radiation, and other dry skin issues caused by medical conditions.